Results 171 to 180 of about 130,645 (352)
CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia. [PDF]
Perkins B +9 more
europepmc +1 more source
The Cleavage Efficiency of the Human Immunoglobulin Heavy Chain VH Elements by the RAG Complex
Kefei Yu, Alex Taghva, Michael R. Lieber
openalex +1 more source
Isolation of mRNA coding for immunoglobulin heavy chain [PDF]
R H, Stevens, A R, Williamson
openaire +2 more sources
Immunophenotypic characteristics of plasma cells in POEMS syndrome
Abstract To analyze the immunophenotypic characteristics of plasma cells in patients with polyneuropathy, organomegaly, endocrinopathy, myeloma protein, and skin changes (POEMS) syndrome. This retrospective study included patients with POEMS syndrome hospitalized in the Department of Hematology, Huashan Hospital, from September 2017 to August 2025 ...
Zhenhua Wang +6 more
wiley +1 more source
From IgZ to IgT: A Call for a Common Nomenclature for Immunoglobulin Heavy Chain Genes of Ray-Finned Fish. [PDF]
Dornburg A +12 more
europepmc +1 more source
This work developed a low‐temperature sludge hydrothermal coupled with gel crosslinking strategy which could upgrade the waste liquid generated from sewage sludge hydrothermal treatment into the hydrothermal‐liquid‐gel. The inventive hydrothermal‐liquid‐gel exhibited the enhanced pollutant removal capability, high synthetic stability, and superior ...
Zifan Liu +12 more
wiley +1 more source
Flexible Direct‐Conversion X‐Ray Detectors: From Emerging Materials to Conformal Imaging
This comprehensive review analyzed the performance, challenges, and future directions of four emerging material systems for next‐generation flexible direct‐conversion X‐ray detectors: organic semiconductors, perovskites, metal–organic frameworks, and inorganic metal compounds.
Haipeng Di +11 more
wiley +1 more source
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source

